ERBB2 and breast cancer: Another study revealed that inhibition of AURKA and PAK1 synergistically decreased survival of cancer cells and tumor growth in luminal and HER2-enriched breast cancer patient-derived xenograft mouse models (Korobeynikov et al., 2019).